Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atopic dermatitis.

William Abramovits1

  • 1Texas Dermatology Associates, Dallas, TX 75230, USA. waresearch@texasderm.com

Journal of the American Academy of Dermatology
|June 22, 2005
PubMed
Summary
This summary is machine-generated.

Atopic dermatitis (AD) involves immunoglobulin E (IgE) antibodies, with most patients overproducing IgE. Environmental factors interacting with genes contribute to AD development and chronic inflammation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feasibility and Patient Experiences in a WhatsApp-Based Educational Pilot for Spanish-Speaking Adults With Chronic Spontaneous Urticaria.

International journal of dermatology·2026
Same author

Zelsuvmi<sup>TM</sup> (Berdazimer) Topical Gel.

Skinmed·2025
Same author

Filsuvez<sup>®</sup> (Birch Triterpenes) Topical Gel.

Skinmed·2025
Same author

BIMZELX<sup>®</sup> (Bimekizumab-bkzx) Injection, for Subcutaneous Use.

Skinmed·2024
Same author

CABTREO<sup>TM</sup> (Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide) Topical Gel.

Skinmed·2024
Same author

Animal Signs in Dermatology: A Furry Approach to Remembering Various Dermatologic Conditions.

Skinmed·2024
Same journal

Highlights from JAAD Case Reports: September 2026: Repurposing established therapies through biologic insight.

Journal of the American Academy of Dermatology·2026
Same journal

First-Come, First-Served: Ethics of Coordinated Interview Releases.

Journal of the American Academy of Dermatology·2026
Same journal

Ethical Implications of Integrating Artificial Intelligence Tools into Dermatology Electronic Health Records.

Journal of the American Academy of Dermatology·2026
Same journal

Real-world experience with extended deucravacitinib-biologic combination therapy in refractory psoriasis and psoriatic arthritis.

Journal of the American Academy of Dermatology·2026
Same journal

Acute-phase Disease and Super-responder Status Predict Reduced Relapse Risk After Ritlecitinib Withdrawal in Alopecia Areata: A Prospective Real-World Study.

Journal of the American Academy of Dermatology·2026
Same journal

Response to Kvist-Hansen et al. 'Baseline monocytes ≥925/μL appear to represent a rare outlier phenotype rather than a generalizable predictor of adalimumab response in hidradenitis suppurativa.'

Journal of the American Academy of Dermatology·2026
See all related articles

Area of Science:

  • Immunology
  • Dermatology
  • Genetics

Background:

  • Atopic dermatitis (AD) is frequently linked to immunoglobulin E (IgE) antibody mechanisms.
  • Most AD patients show IgE hyperproduction, especially during disease flares.
  • IgE-dependent reactions can perpetuate chronic inflammation in AD.

Purpose of the Study:

  • To review the role of immunoglobulin E (IgE) in atopic dermatitis (AD).
  • To discuss the interplay between genetics and environmental factors in AD pathogenesis.
  • To highlight current therapeutic strategies and future research directions for AD.

Main Methods:

  • Review of existing literature on atopic dermatitis pathophysiology.
  • Analysis of the role of IgE in AD immune responses.

Related Experiment Videos

  • Discussion of genetic and environmental influences on AD.

    • Main Results:

    • IgE hyperproduction is a hallmark of AD, particularly during flares.
    • Environmental factors (allergens, microbes, stress) interact with genetic susceptibility.
    • Complex immune responses contribute to chronic inflammation in AD.

    Conclusions:

    • Understanding AD pathophysiology, including IgE's role, enables rational therapeutic interventions.
    • Combined therapies offer immediate relief and long-term AD management.
    • Future research focusing on AD-associated genes and immunoregulatory mechanisms is crucial.